Literature DB >> 19168069

Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.

Suksanti Prakobwong1, Somchai Pinlaor, Puangrat Yongvanit, Paiboon Sithithaworn, Chawalit Pairojkul, Yusuke Hiraku.   

Abstract

The liver fluke Opisthorchis viverrini is endemic in southeastern Asia, and causes cholangiocarcinoma and liver fibrosis. We investigated the time profile of the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) in relation to peribiliary fibrosis in O. viverrini-infected hamsters. Hepatic mRNA expression of MMPs, TIMPs, cytokines and collagens I and III was assessed by quantitative reverse transcription-PCR. Zymography and immunohistochemistry were also used to examine MMPs-2 and -9 expression. After infection, an increase of peribiliary fibrosis was time-dependent. Opisthorhis viverrini-induced gene expression in hamster liver, with increased mRNA expression levels of IL-1beta, TNF-alpha, TGF-beta, and collagens I and III, was observed at 21 days p.i. Expression of MMPs-2, -13 and -14 and TIMPs-1 and -3 genes, was significantly higher at 1 month, and maximal levels of most MMPs (MMPs-2, -9, -13 and -14) were observed at 2 months p.i. The cytoplasmic levels of MMP-2 and MMP-9 were similar to mRNA expression. Immunohistochemistry revealed that MMP-9 was expressed mainly in the cytoplasm of inflammatory cells at the invasive front of the fibrous area. In contrast, the highest levels of mRNA expression of TIMPs-2 and -3, and TGF-beta were observed 10 months p.i. Concentration of TIMP-2 protein in the plasma correlated with its transcriptional level (r=0.320, P=0.040). Peribiliary fibrosis correlated positively with liver hydroxyproline content (r=0.846, P<0.001), plasma hydroxyproline concentration (r=0.770, P<0.001), plasma TIMP-2 level (r=0.335, P=0.046), and mRNA expression levels of MMP-7 (r=0.511, P=0.006), TIMP-1 (r=0.320, P=0.040), TIMP-2 (r=0.428, P=0.026), and TIMP-3 (r=0.553, P=0.003). This study suggests that expression of MMPs is associated with an inflammatory reaction in the early phase and TIMPs expression at the late phase may contribute to both fibrosis and liver injury. MMPs and TIMPs may serve as diagnostic markers for the severity of O. viverrini-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168069     DOI: 10.1016/j.ijpara.2008.12.002

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  28 in total

1.  Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen.

Authors:  Puangrat Yongvanit; Raynoo Thanan; Somchai Pinlaor; Paiboon Sithithaworn; Watcharin Loilome; Nisana Namwat; Anchalee Techasen; Somkid Dechakhamphu
Journal:  Parasitol Res       Date:  2011-12-09       Impact factor: 2.289

2.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

3.  A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.

Authors:  Lipika Goyal; Hui Zheng; Matthew B Yurgelun; Thomas A Abrams; Jill N Allen; James M Cleary; Michelle Knowles; Eileen Regan; Amanda Reardon; Anna Khachatryan; Rakesh K Jain; Valentina Nardi; Darrell R Borger; Dan G Duda; Andrew X Zhu
Journal:  Cancer       Date:  2017-02-13       Impact factor: 6.860

4.  Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.

Authors:  Banchob Sripa; Eimorn Mairiang; Bandit Thinkhamrop; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Smarn Tessana; Alex Loukas; Paul J Brindley; Jeffrey M Bethony
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

5.  Cytokine/chemokine secretion and proteomic identification of upregulated annexin A1 from peripheral blood mononuclear cells cocultured with the liver fluke Opisthorchis viverrini.

Authors:  Nuttanan Hongsrichan; Kitti Intuyod; Porntip Pinlaor; Jarinya Khoontawad; Puangrat Yongvanit; Chaisiri Wongkham; Sittiruk Roytrakul; Somchai Pinlaor
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

6.  Coinfection with Helicobacter pylori and Opisthorchis viverrini Enhances the Severity of Hepatobiliary Abnormalities in Hamsters.

Authors:  Rungtiwa Dangtakot; Somchai Pinlaor; Upsornsawan Itthitaetrakool; Apisit Chaidee; Chariya Chomvarin; Arunnee Sangka; Chotechana Wilailuckana; Porntip Pinlaor
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

7.  Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.

Authors:  P Chusorn; N Namwat; W Loilome; A Techasen; C Pairojkul; N Khuntikeo; A Dechakhamphu; C Talabnin; W Chan-On; C K Ong; B T Teh; P Yongvanit
Journal:  Tumour Biol       Date:  2013-02-17

Review 8.  Cholangiocarcinoma: new insights into disease pathogenesis and biology.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Infect Dis Clin North Am       Date:  2010-12       Impact factor: 5.982

9.  Matrix metalloproteinase inhibition influences aspects of photoperiod stimulated ovarian recrudescence in Siberian hamsters.

Authors:  Asha Shahed; Jamie J Simmons; Sydney L Featherstone; Kelly A Young
Journal:  Gen Comp Endocrinol       Date:  2015-04-21       Impact factor: 2.822

10.  PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.

Authors:  Watcharin Loilome; Sasithorn Yooyuen; Nisana Namwat; Paiboon Sithithaworn; Anucha Puapairoj; Junko Kano; Masayuki Noguchi; Masanao Miwa; Puangrat Yongvanit
Journal:  Tumour Biol       Date:  2012-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.